Written question asked by Lord Hunt of Kings Heath (Labour) on Wednesday, 20 July 2016, in the House of Lords. It was due for an answer on Wednesday, 3 August 2016. It was answered by Lord Prior of Brampton (Conservative) on Tuesday, 2 August 2016 on behalf of the Department of Health.
Joint Committee on Vaccination and Immunisation
- Question
-
To ask Her Majesty’s Government what assessment they have made of the implications of the Joint Committee on Vaccination and Immunisation (JCVI) operating differently to other health technology assessment bodies, such as NICE, as stated in the minutes of the June JCVI meeting, in the event that the recommendations of the Cost Effectiveness Methodology for Immunisation Programmes and Procurements working group are adopted.
- Answer
-
The report of the Cost Effectiveness Methodology for Immunisation Programmes and Procurement (CEMIPP) review was received in the Department on 20 July. The Department is considering this report and its potential implications.
Secondary information
- Type
- Written question
- Reference
- HL1362
- Session
- 2016-17
- Grouped for answer
- Yes
- Subjects
- Cost effectiveness Vaccination Joint Committee on Vaccination and Immunisation
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2016-08-11 16:24:04 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2016-17/HL1362
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2016-17/HL1362
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2016-17/HL1362